Skip to main content
. 2019 Apr 14;20(8):1844. doi: 10.3390/ijms20081844
AMPK AMP-activated protein kinase
ANOVA Analysis of variance
COMB Combination group
CTRL Placebo group
FDA Food and Drug Administration
FLU Fluvastatin group
FMD Flow mediated dilation
hTERT human telomerase reverse transcriptase
MILES Metformin in Longevity Study
mTOR Mechanistic target of rapamycin
NAD Nicotinamide adenine dinucleotide
NF-κB1 Nuclear factor κB
NFE2L2 Nuclear factor (erythroid-derived 2)-like 2 gene
PRKAA 5′-AMP-activated protein kinase catalytic subunit α-2 gene
PWV Pulse wave velocity
qPCR Quantitative real-time polymerase chain reaction
SIRT1 Sirtuin 1 gene
VAL Valsartan group